Skip to main content
    A

    Astera Labs, Inc. (ALAB)

    Official site

    TECHNOLOGY • SEMICONDUCTORS • NASDAQ

    $202.34
    -19.49 (-8.79%)

    Market Cap: $38.77B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Astera Labs, Inc. (ALAB) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Astera Labs (ALAB) trades at 75.8x trailing earnings and 22.6x sales. Its forward P/E is 32.7x. The median P/E across 11 similar companies is 32.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 131.8% higher over the next year. Its free cash flow yield is 1.0%.

    MultipleValue
    P/E (trailing)75.8x
    Forward P/E32.7x
    Price to sales22.6x
    Price to book17.6x
    EV/EBITDA85.9x
    Price to FCF102.2x
    EV/FCF101.6x
    PEGN/A
    FCF yield1.0%

    As of Nov 17, 2026

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ALAB

    What is ALAB's forward P/E ratio?

    Astera Labs has a forward P/E ratio of 32.7x.

    Is ALAB stock overvalued?

    GNG's valuation label for ALAB is Undervalued. Its P/E of 75.8x compares with a median of 32.8x across 11 similar companies.

    What is ALAB's price to sales ratio?

    Astera Labs has a price to sales ratio of 22.6x.